Direct-Acting Antiviral Therapy in Liver Transplant Patients With Hepatocellular Carcinoma and Hepatitis C.

Transplant Direct · 2021 · PMC7725260 · PMID 33324740

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceP = 0.06so close (0.05 < p ≤ 0.1)

showed a trendno p-value reported

Those who received pretransplant DAA showed a trend toward a higher risk of posttransplant HCC recurrence (5/18, 27.8%) compared with untreated patients (6/63, 9.5%), but this did not reach statistical significance ( P = 0.06).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.